Brawn Biotech Limited (BOM:530207)

India flag India · Delayed Price · Currency is INR
20.27
-0.97 (-4.57%)
At close: Mar 6, 2026
Market Cap60.82M -9.3%
Revenue (ttm)172.71M +17.9%
Net Income-790.80K
EPS-0.27
Shares Out3.00M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume2,600
Average Volume750
Open22.30
Previous Close21.24
Day's Range20.27 - 22.30
52-Week Range15.46 - 24.37
Beta0.12
RSI48.66
Earnings DateFeb 14, 2026

About Brawn Biotech

Brawn Biotech Limited engages in the trading of pharmaceutical products in India. It provides pharmaceutical formulations, including antibacterial, cardiovascular, antidiabetic, analgesic, gastrointestinal, antifungal, skin care, antipsychotic, antiasthmatic, antacid, antimalarial, and nutritional products. The company was formerly known as Brawn Pharmaceuticals Limited and changed its name to Brawn Biotech Limited in November 2010. The company was incorporated in 1985 and is based in New Delhi, India. [Read more]

Industry Pharmaceutical Preparations
Founded 1985
Employees 9
Stock Exchange Bombay Stock Exchange
Ticker Symbol 530207
Full Company Profile

Financial Performance

In fiscal year 2025, Brawn Biotech's revenue was 134.75 million, a decrease of -18.30% compared to the previous year's 164.95 million. Losses were -17.40 million, 39.5% more than in 2024.

Financial Statements